149 related articles for article (PubMed ID: 11820306)
21. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
22. Detection of factor V leiden and prothrombin gene mutations in patients who died with thrombotic events.
Ranguelov RD; Rosenthal N; Bromley C; Vasef MA
Arch Pathol Lab Med; 2002 Oct; 126(10):1193-6. PubMed ID: 12296757
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
[TBL] [Abstract][Full Text] [Related]
25. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
Larsson J
Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
[TBL] [Abstract][Full Text] [Related]
26. The role of factor V Leiden and prothrombin G20210A mutations in sudden sensorineural hearing loss.
Görür K; Tuncer U; Eskandari G; Ozcan C; Unal M; Ozsahinoglu C
Otol Neurotol; 2005 Jul; 26(4):599-601. PubMed ID: 16015153
[TBL] [Abstract][Full Text] [Related]
27. Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.
Topaloglu R; Akierli C; Bakkaloglu A; Aydintug O; Ozen S; Besbas N; Ozcelik T
Clin Rheumatol; 2001; 20(4):259-61. PubMed ID: 11529632
[TBL] [Abstract][Full Text] [Related]
28. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
29. Retinal vascular occlusion and deficiencies in the protein C pathway.
Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
[TBL] [Abstract][Full Text] [Related]
30. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer.
Battistelli S; Stefanoni M; Genovese A; Vittoria A; Cappelli R; Roviello F
World J Gastroenterol; 2006 Jul; 12(26):4179-80. PubMed ID: 16830369
[TBL] [Abstract][Full Text] [Related]
32. Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations.
Ben-Ami R; Zeltser D; Leibowitz I; Berliner SA
Blood Coagul Fibrinolysis; 2002 Jan; 13(1):57-9. PubMed ID: 11994569
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
[TBL] [Abstract][Full Text] [Related]
34. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
Spagnolo BV; Nasrallah FP
Retina; 1998; 18(4):377-8. PubMed ID: 9730185
[No Abstract] [Full Text] [Related]
35. Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion.
Johnson TM; El-Defrawy S; Hodge WG; Leonard BC; Kertes PJ; Taylor SAM ; Lillicrap DP
Retina; 2001; 21(2):161-6. PubMed ID: 11321143
[TBL] [Abstract][Full Text] [Related]
36. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.
Foka ZJ; Lambropoulos AF; Saravelos H; Karas GB; Karavida A; Agorastos T; Zournatzi V; Makris PE; Bontis J; Kotsis A
Hum Reprod; 2000 Feb; 15(2):458-62. PubMed ID: 10655323
[TBL] [Abstract][Full Text] [Related]
37. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.
Larsson J; Hillarp A
Thromb Res; 1999 Nov; 96(4):323-7. PubMed ID: 10593436
[TBL] [Abstract][Full Text] [Related]
38. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
39. Factor V Leiden mutation with retinal vascular occlusion.
Keane PA; Sadda SR
Intern Med J; 2010 Dec; 40(12):859-60. PubMed ID: 21199226
[No Abstract] [Full Text] [Related]
40. Idiopathic central retinal vein occlusion in 2 siblings with the 20210 G-->A prothrombin variant.
Peris-Martínez C; Díaz-Llopis M; Menezo JL
Arch Ophthalmol; 2002 Dec; 120(12):1752-4. PubMed ID: 12470156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
